Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

GSK1820795A

Copy Product Info
🥰Excellent

Synonyms:

Catalog No. T64011 Copy Product Info
Purity: 99.78%
🥰Excellent
GSK1820795A is a selective G2A/GPR132a antagonist and a telmisartan analog. GSK1820795A also exhibits angiotensin II receptor antagonist activity and partial PPARγ agonist activity. GSK1820795A effectively blocks the activating effects of N-acylamides on yeast cells expressing hGPR132a.
GSK1820795A
Cas No. 2650253-86-2
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$163-In Stock
5 mg$419-In Stock
10 mg$679-In Stock
25 mg$1,360-In Stock
50 mg$1,980-In Stock
100 mg$2,500-In Stock
1 mL x 10 mM (in DMSO)$526-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
Custom-made molecule. TargetMol’s expert synthesis team delivers cost-effective solutions. Contact us for inquiries. Committed to serving you.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.78%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
GSK1820795A is a selective G2A/GPR132a antagonist and a telmisartan analog. GSK1820795A also exhibits angiotensin II receptor antagonist activity and partial PPARγ agonist activity. GSK1820795A effectively blocks the activating effects of N-acylamides on yeast cells expressing hGPR132a.
Targets & IC50
PPARγ (mouse):0.27 μM (EC50), AT1 Receptor:0.006 μM, PPARγ (human):0.25 μM (EC50)
Chemical Properties
Molecular Weight566.70
FormulaC35H34N8
Cas No.2650253-86-2
SmilesN1=NNC(=N1)C=2C=CC=CC2C=3C=CC(=CC3)CC4=C5C=C(C=CC5=NN4CCC)C6=NC=7C=CC=CC7N6CCCC
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (141.17 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.7646 mL8.8230 mL17.6460 mL88.2301 mL
5 mM0.3529 mL1.7646 mL3.5292 mL17.6460 mL
10 mM0.1765 mL0.8823 mL1.7646 mL8.8230 mL
20 mM0.0882 mL0.4412 mL0.8823 mL4.4115 mL
50 mM0.0353 mL0.1765 mL0.3529 mL1.7646 mL
100 mM0.0176 mL0.0882 mL0.1765 mL0.8823 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 µL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 µL Tween 80 and mix well until fully clarified.

3) Add 450 µL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
µL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: GSK1820795A chemical structure | GSK1820795A formula | GSK1820795A molecular weight